Skip to content

Next Technology Holding NXTT Granted (in dollars per share)

Granted (in dollars per share) at other companies

Alto Ingredients, Inc. logo
Alto Ingredients, Inc.ALTO
$1.16-39.3%
NXT
Next Technology HoldingNXTT
$1.85
CHE
ChemedCHE
514.4-8.8%
Norwood Financial logo
Norwood FinancialNWFL
29.6+8.8%
BCB Bancorp logo
BCB BancorpBCBP
7.5-29.7%
DJT
Trump Media & Technology GroupDJT
$0.00

Other financials

Income statement

See full
Revenue$465.2K
Gross profit$77.9K
Operating income-$6.6M-1,375%
Net income-$105.9M-155%
EPS (diluted)-$11.86-103%

Balance sheet

See full
Cash & equivalents$668.4K0.0%
Total debt$575.6K
Total equity$510.9M+21.3%
Total assets$551.2M+13.9%

Cash flow

See full
Operating cash flow-$1.4M
CapEx--100%
Free cash flow-$552.7K-110%

Valuation

See full
Market cap$84.65M-89.7%
Enterprise value$84.56M-89.7%
P/E0.5×
P/S6.8×+4.0×

Profitability

See full
Gross margin59.4%+0.5pp
Operating margin-180.8%
Net margin1,196.8%
FCF margin-438.9%-453pp

Returns & leverage

See full
Return on equity93.2%
Debt / equity
Current ratio180.9×+27.0×

Where this comes from

Reported directly by Next Technology Holding in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.

The official record: Next Technology Holding’s 10-K, filed March 31, 2026, on SEC EDGAR. View the filing →

Ask your AI about Next Technology Holding's granted (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Next Technology Holding's granted (in dollars per share)?
Next Technology Holding (NXTT) reported granted (in dollars per share) of $1.85 in Q4 2025.
What does granted (in dollars per share) mean?
The weighted average grant-date fair value per share for equity instruments awarded to personnel. This metric provides insight into the cost of equity-based compensation and the company's valuation of its own stock for incentive purposes.